EcoDrugPlus

Utrophin

Ensembl ID : ENSBBBG00000021890
Gene Symbol: UTRN
3 Cross references
268 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSBBBG00000004895
Gene Symbol: VEGFA
3 Cross references
254 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSBBBG00000014238
Gene Symbol: VDR
3 Cross references
466 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSBBBG00000003910
Gene Symbol: VKORC1
3 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSBBBG00000004637
Gene Symbol: XDH
3 Cross references
210 Possible Orthologues:

Ensembl ID : ENSBBBG00000014608
Gene Symbol: -
Cross references: -
276 Possible Orthologues:

Ensembl ID : ENSBBBG00000015779
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSBBBG00000015783
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSBBBG00000016085
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSBBBG00000016148
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSBBBG00000018460
Gene Symbol: -
Cross references: -
344 Possible Orthologues:

Ensembl ID : ENSBBBG00000018484
Gene Symbol: -
Cross references: -
268 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).